Eugin Group is an international group of assisted reproduction and fertility centers, with 25 years of experience. In total, the group performs more than 45,000 treatments per year and, since its inauguration in Barcelona in 1998, has helped bring 265,000 babies into the world.

Eugin stands out for offering personalized solutions in all fields of assisted reproduction, especially in treatments that require specialized procedures, as well as for its strong commitment to research, for which it has its own R&D team of 25 people dedicated entirely to this task.

Likewise, Eugin’s team is an active part of the national and international fertility societies of reference, participates in the most relevant scientific congresses, and carries out important outreach work through its event, EBART Congress, and many collaboration with universities all around the globe.

For the past 8 years, the Eugin Group has been hosting EBART (Evidence-Based Assisted Reproductive Technologies), an international congress, now in its fifth edition.

It aims to address the hottest topics in the field of reproductive medicine, in a critical and independent spirit, fostering evidence-based discussions and knowledge sharing among practitioners, researchers and thought leaders from around the world.

EBART stands out for its commitment to bold, innovative thinking that challenges the status quo. Get ready for an enriching experience where we come together to shape the future of ART, always placing the patient at the forefront.

Congress Organising Committee

Amelia Rodríguez-Aranda, MD PhD

Eugin Group Medical Director

Mina Popovic, PHD​

Eugin Group Scientific Director